A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...

The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.

The U.S. Food and Drug Administration (FDA) has cleared another blood test that could help doctors identify whether a patient ...

EKZ-102, an experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical testing in ...

Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease - Millions of Americans are ...